InvestorsHub Logo
Followers 12
Posts 360
Boards Moderated 0
Alias Born 05/09/2014

Re: None

Wednesday, 07/20/2022 3:49:39 PM

Wednesday, July 20, 2022 3:49:39 PM

Post# of 118359
New 8-K Filing - Debt gone!
https://www.sec.gov/ix?doc=/Archives/edgar/data/0001589150/000160706222000464/rgbp072022form8k.htm

On July 19, 2022 Regen Biopharma, Inc. (the “Company”) issued 54,514,492 common shares (“Shares”) to Coventry Enterprises LLC in satisfaction of $180,552 of convertible indebtedness. The principal balance and accrued interest payable remaining on the $1,500,000 promissory note issued to Coventry Enterprises LLC are both $0 as of July 19,2022.

Good Luck!